Evidence map›Paper›PMID 25288577›Full record

ArticleUrology2014

Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men.

Ranjith Ramasamy, Nathan Wilken, Jason M Scovell, Jason R Kovac, Larry I Lipshultz

Abstract read
In one paragraph

Article in Urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function.The aging male : the official journal of the International Society for the Study of the Aging Male · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ranjith RamasamyDepartment of Urology, Baylor College of Medicine, Houston, TX.
Nathan WilkenDepartment of Urology, Baylor College of Medicine, Houston, TX.
Jason M ScovellDepartment of Urology, Baylor College of Medicine, Houston, TX.
Jason R KovacDepartment of Urology, Baylor College of Medicine, Houston, TX.
Larry I LipshultzDepartment of Urology, Baylor College of Medicine, Houston, TX. Electronic address: larryl@bcm.edu.

Funding

K-12: Male Reproductive Health Research (MRHR) Career Development Program at BCMK12HD073917 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LAMB, DOLORES JEAN · 2012 to 2016
$1.7M
NICHD NIH HHS K12 HD073917
6 · The paper itself

Abstract

objectiveTo determine the association between hypogonadal symptoms and total serum testosterone levels in middle-aged and elderly men (aged > 40 years), and to identify whether there exists a clear-cut discriminatory threshold of total testosterone below which the probability of hypogonadal symptoms increases.

methodsWe retrospectively reviewed the charts of 360 men who presented to an outpatient men's health clinic with a chief complaint of low testosterone. Sexual, psychological, and physical symptoms were evaluated using the androgen deficiency in the aging male (ADAM) questionnaire. Serum levels of total testosterone were collected on the same day on which men completed their ADAM questionnaires. We performed the univariate (t test, chi-square, and binary logistic regression) and multivariate analyses (binary logistic regression) to evaluate the total testosterone threshold and the symptoms that predicted a low-testosterone level.

resultsA cluster of symptoms: 1 sexual (decreased libido), 1 psychological (decreased energy), and 3 physical (decreased strength or endurance, decreased ability to play sports, and falling asleep after dinner) were most associated with total serum testosterone levels of ≤ 300 ng/dL. The threshold testosterone serum levels that were associated with an increased prevalence of these hypogonadal symptoms ranged from 320 to 375 ng/dL. On multivariate analysis, age, but not symptoms on the ADAM questionnaire, predicted a total testosterone level of < 300 ng/dL.

conclusionA distinct constellation of hypogonadal symptoms exists at various serum testosterone levels. Consequently, identification of the thresholds for specific symptom management will be critical in establishing patient-centered treatment algorithms.

Indexed as

Surveys and QuestionnairesAgedAged, 80 and overAge FactorsAgingCohort StudiesConfidence IntervalsHumansHypogonadismLibidoMaleMiddle AgedMultivariate AnalysisOdds RatioRetrospective StudiesRisk AssessmentTestosterone

Identifiers

PMID25288577
PMCPMC4247997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.